Medical devices

inPROBE – future of breast cancer diagnosis

Global potential to replace current IHC and FISH cancer diagnostics with possible far less-invasive substitution to the biopsy cancer diagnostics
inPROBE, invented and developed by SDS Optic, is cancer diagnosis device designed to reduce time of medical diagnosis, increase precision and effects of advanced cancer treatments and most importantly – help medical professionals to save lives of milions of patients worldwide. It can be used both in cancer diagnostics and ther- apies monitoring in real-time and natural state (in vivo), thus giving the medical professionals tools and methods previously unavailable.

Key benefits

Real time diagnostics
Cancer biomarkers testing results (currently HER2) are presented live on the screen

Objective results  
Results are objective, numerical and easy to read.

Patients wellbeing
No need for the tissue acquisition from the patient’s body and micro-size of the needle are significantly less painful than biopsy.

How it works

inPROBE is a nano-size glass probe getting in vivo within very thin biopsy needle, connected with detecting device and with innovative components at the tip of the probe. Thanks to its thicknes it is safer, much less stressful and much less painful.

Fast and precise cancer diagnosis combined with modern therapies can help to SAVE UP TO 30% of people diagnosed with cancer by year 2030.
Thanks to high sensitivity inProbe can examine even single cells. It also allows to get close to the tumor without the need to get into the tumor as today, which can lead to malignant cancer.

All the data gathered during procedure is transferred via fiber optics into the multi- purpose detecting device. Then the data is calculated using specific algorithms and presented to the oncologist as a diagnostic result – a numerical measure with exact level of tested components (e.g. HER2 cancer biomarker).

During the cancer therapies inProbe will be able to measure active ingredient level (f.e. Trastuzumab) in cancer tumor cells, thus supporting & improving the efficiency of modern targeted cancer therapies and petients’ well-being.


SDS-MicroProbe can be a groundbreaking solution to overcome problems in current technology and enable analysis of biological processes inside the single cell in their natural state. As an expert in hematology, I am convinced that such solution would find several applications in research as well as in future cell therapies in the cancer area.

Hematologist/Oncologist M.D. PhD
with several years of scientific experience at NIH
Bethesda, MD, USA

There is an unmet need to study biological processes within individual cells residing in their native niche. The SDS-MicroProbe addresses this shortcoming; it is a new approach in analyzing key intracellular parameters that indicate the functionality of a cell. The SDS-MicroProbe has the potential to substantially advance our ability to assess the status of living cells and thereby improve our ability to diagnose various diseases and evaluate the efficiency of interventions.

Profesor, PhD of Harvard Medical School
Boston, MA, USA



If you want to know something more about our project, here you can download the newest brochure or visit our website